Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New alpha-protein kinase 1 activators discovered at Shanghai Yaoyuan Biotechnology

Nov. 16, 2020

Reversal of pumping direction is reversal of fortune for tumor cells

Nov. 16, 2020

Bayer, The Broad Institute identify new KAT6A and/or KAT6B inhibitors

Nov. 16, 2020

First patient dosed in phase I study of BBP-398

Nov. 16, 2020

First patient dosed in phase II study of tomivosertib plus chemotherapy in breast cancer

Nov. 13, 2020

Safety, pharmacology and preliminary efficacy of VT-1021 in patients with advanced solid tumors

Nov. 13, 2020

Betta Pharmaceuticals synthesizes new KRAS mutant inhibitors

Nov. 13, 2020

Epitas Biosciences presents IDH2 inhibitors

Nov. 13, 2020

HitGen patents HDAC inhibitors

Nov. 13, 2020

First patient treated in phase I study of MaaT-033

Nov. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...